444 results on '"Tunney, Michael M"'
Search Results
2. Inhaled dry powder liposomal azithromycin for treatment of chronic lower respiratory tract infection
3. Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment
4. Antimicrobial resistance in urinary pathogens and culture-independent detection of trimethoprim resistance in urine from patients with urinary tract infection
5. Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
6. In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis
7. Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftor
8. Characterization of clinical Ralstonia strains and their taxonomic position
9. Influence of azithromycin and allograft rejection on the post–lung transplant microbiota
10. Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations
11. Development of a core outcome set for clinical trials aimed at improving antimicrobial stewardship in care homes
12. Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis
13. Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review
14. The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?
15. Effect of treatment with tobramycin on the airway microbiota and resistome in bronchiectasis patients chronically colonised with Pseudomonas aeruginosa: iBEST study
16. Interventions to Improve Antimicrobial Stewardship for Older People in Care Homes: A Systematic Review
17. Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist
18. Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens
19. Lung function and microbiota diversity in cystic fibrosis
20. Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens
21. Lung Clearance Index in Adults and Children With Cystic Fibrosis
22. Eradication and phenotypic tolerance of Burkholderia cenocepacia biofilms exposed to atmospheric pressure non-thermal plasma
23. Production of extended-spectrum β-lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiota
24. Fusobacterium nucleatum: a novel immune modulator in breast cancer?
25. Predictors of adherence to treatment in bronchiectasis
26. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
27. BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs
28. CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With Ivacaftor
29. Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes
30. Whole-genome analysis of Haemophilus influenzae strains isolated from persons with cystic fibrosis
31. Characterization of Bacteria Using Surface-Enhanced Raman Spectroscopy (SERS): Influence of Microbiological Factors on the SERS Spectra
32. Molecular detection of CF lung pathogens: Current status and future potential
33. Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy
34. Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
35. Taxonomic position, antibiotic resistance and virulence factors of clinical Achromobacter isolates
36. Novel freeze-dried DDA and TPGS liposomes are suitable for nasal delivery of vaccine
37. Electrically-responsive anti-adherent hydrogels for photodynamic antimicrobial chemotherapy
38. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions
39. Photodynamic Antimicrobial Chemotherapy (PACT) in combination with antibiotics for treatment of Burkholderia cepacia complex infection
40. The Effects of Agrimonia pilosa Ledeb, Anemone chinensis Bunge, and Smilax glabra Roxb on Broiler Performance, Nutrient Digestibility, and Gastrointestinal Tract Microorganisms
41. Taxonomic position, antibiotic resistance and virulence factors of clinical Achromobacter isolates
42. Microbial Community Composition in Explanted Cystic Fibrosis and Control Donor Lungs
43. Additional file 1 of Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
44. Additional file 1 of Antimicrobial resistance in urinary pathogens and culture-independent detection of trimethoprim resistance in urine from patients with urinary tract infection
45. Additional file 3 of Antimicrobial resistance in urinary pathogens and culture-independent detection of trimethoprim resistance in urine from patients with urinary tract infection
46. Additional file 4 of Antimicrobial resistance in urinary pathogens and culture-independent detection of trimethoprim resistance in urine from patients with urinary tract infection
47. Additional file 2 of Antimicrobial resistance in urinary pathogens and culture-independent detection of trimethoprim resistance in urine from patients with urinary tract infection
48. Additional file 4 of Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections
49. Drug and light delivery strategies for photodynamic antimicrobial chemotherapy (PACT) of pulmonary pathogens: A pilot study
50. Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.